Pages that link to "Q39542053"
Jump to navigation
Jump to search
The following pages link to Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest (Q39542053):
Displaying 27 items.
- Salinomycin as a drug for targeting human cancer stem cells (Q21285139) (← links)
- Salinomycin: a novel anti-cancer agent with known anti-coccidial activities (Q26853644) (← links)
- Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells (Q33633349) (← links)
- Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206. (Q33992871) (← links)
- Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro (Q34443640) (← links)
- Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma. (Q34610115) (← links)
- A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer (Q35176048) (← links)
- Thioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition (Q35200564) (← links)
- Maduramicin inhibits proliferation and induces apoptosis in myoblast cells (Q35532104) (← links)
- Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis (Q35983858) (← links)
- Lower salinomycin concentration increases apoptotic detachment in high-density cancer cells (Q36396532) (← links)
- Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance (Q36892078) (← links)
- Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. (Q36985137) (← links)
- Low amount of salinomycin greatly increases Akt activation, but reduces activated p70S6K levels (Q37225029) (← links)
- The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy (Q37576360) (← links)
- Low-dose salinomycin induces anti-leukemic responses in AML and MLL. (Q37687407) (← links)
- Lysosomal Biology in Cancer (Q38689342) (← links)
- Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides. (Q38937356) (← links)
- Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status (Q38942314) (← links)
- Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas (Q39075925) (← links)
- Salinomycin: A new paradigm in cancer therapy. (Q39204541) (← links)
- Salinomycin: a new cancer drug candidate (Q39432450) (← links)
- Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin. (Q42826454) (← links)
- Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review (Q50057844) (← links)
- Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. (Q51028754) (← links)
- Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk. (Q55456963) (← links)
- Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex (Q93007014) (← links)